Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Performance of an Omics-signature in the Diagnosis and Prognosis of Endocrine and Primary Hypertension

NCT02772315 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT02772315
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02772315 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Performance of an Omics-signature in the Diagnosis and Prognosis of Endocrine and Primary Hypertension
Lead sponsor
Radboud University Medical Center
Phase
Observational
Overall status
Unknown status
Start date
August 31, 2016
Completion date
May 31, 2019
Enrollment
4,000 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension